Sponsor pipeline

Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd clinical trial pipeline

Get alerts when Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
3

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT07156253 Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid… Metastatic Solid Tumor Recruiting 2025-09-05
NCT06666270 Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors Advanced Solid Cancer Recruiting 2025-07-20
NCT07088588 Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors Advanced Solid Cancer Not Yet Recruiting 2025-07-28

Disease areas by active trials

Breast Cancer (3) · Ovarian Cancer (3) · Prostate Cancer (1)

Get alerts when Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free